Net profit of Alivus Life Sciences rose 36.41% to Rs 130.03 crore in the quarter ended September 2025 as against Rs 95.32 crore during the previous quarter ended September 2024. Sales rose 16.00% to Rs 587.98 crore in the quarter ended September 2025 as against Rs 506.88 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales587.98506.88 16 OPM %30.4726.51 - PBDT192.58142.55 35 PBT174.14127.46 37 NP130.0395.32 36 Powered by Capital Market - Live News

Alivus Life Sciences will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live News

Alivus Life Sciences announced that the Annual General Meeting(AGM) of the company will be held on 8 September 2025.Powered by Capital Market - Live News

Net profit of Alivus Life Sciences rose 9.02% to Rs 121.54 crore in the quarter ended June 2025 as against Rs 111.48 crore during the previous quarter ended June 2024. Sales rose 2.25% to Rs 601.85 crore in the quarter ended June 2025 as against Rs 588.62 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales601.85588.62 2 OPM %28.6327.10 - PBDT180.05164.63 9 PBT162.99150.24 8 NP121.54111.48 9 Powered by Capital Market - Live News

Alivus Life Sciences will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live News